Cargando…

Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections

The aim of this study was to investigate the correlation between CYP2C19 genotype and dose-adjusted voriconazole (VCZ) trough concentrations (C(0)/dose). We analyzed the correlation between CYP2C19(∗)2(681G>A), CYP2C19(∗)3(636G>A), and CYP2C19(∗)17(-806C>T) genetic polymorphisms and the dos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Qiang, Tang, Jiang-Tao, van Gelder, Teun, Li, Ya-Mei, Bai, Yang-Juan, Zou, Yuan-Gao, Wang, Lan-Lan, Shi, Yun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370172/ https://www.ncbi.nlm.nih.gov/pubmed/30653146 http://dx.doi.org/10.1097/MD.0000000000014137

Ejemplares similares

Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections
por: Chuwongwattana, Sumonrat, et al.
Publicado: (2020)

Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients
por: Li, Zi-Wei, et al.
Publicado: (2017)

Therapeutic drug monitoring and CYP2C19 genotyping guide the application of voriconazole in children
por: Chen, Xiaomin, et al.
Publicado: (2022)

Population pharmacokinetics of voriconazole and the role of CYP2C19 genotype on treatment optimization in pediatric patients
por: Hu, Lin, et al.
Publicado: (2023)

Voriconazole in the management of nosocomial invasive fungal infections
por: Pemán, Javier, et al.
Publicado: (2006)

Topical and Oral Voriconazole in the Treatment of Fungal Keratitis
por: Lee, Sang Joon, et al.
Publicado: (2009)

Voriconazole-refractory fungal infection of phacoemulsification tunnel
por: Mittal, Vikas, et al.
Publicado: (2010)

Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis
por: Niki, Masanori, et al.
Publicado: (2014)

Update on the optimal use of voriconazole for invasive fungal infections
por: Lat, Asma, et al.
Publicado: (2011)

Voriconazole Treatment for Fungal Chorioretinitis After Obesity Surgery
por: Savur, Fatma, et al.
Publicado: (2021)

Oral voriconazole monotherapy for fungal keratitis: efficacy, safety, and factors associated with outcomes
por: Cai, Youran, et al.
Publicado: (2023)

Interpersonal Factors in the Pharmacokinetics and Pharmacodynamics of Voriconazole: Are CYP2C19 Genotypes Enough for Us to Make a Clinical Decision?
por: Zhong, Xuefeng, et al.
Publicado: (2018)

Comparison of modified corneal cross-linking with intrastromal voriconazole for the treatment of fungal corneal ulcer
por: Chen, Yingxin, et al.
Publicado: (2021)

Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
por: Shi, Hui-Yan, et al.
Publicado: (2010)

Treatment of chronic invasive fungal sinusitis with voriconazole in an HIV patient
por: Ho, A, et al.
Publicado: (2010)

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
por: Al-Badriyeh, Daoud, et al.
Publicado: (2010)

Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis
por: Malhotra, Sakshi, et al.
Publicado: (2014)

Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis
por: Sun, Yajie, et al.
Publicado: (2018)

Efficacy of Voriconazole Corneal Intrastromal Injection for the Treatment of Fungal Keratitis
por: Li, Chenshuang, et al.
Publicado: (2021)

Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
por: Cai, Jingjing, et al.
Publicado: (2023)

Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole
por: Hall, Victoria G, et al.
Publicado: (2023)

Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT
por: Sienkiewicz, Beata, et al.
Publicado: (2017)

Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis
por: Zhong, Jing, et al.
Publicado: (2018)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
por: Cheng, Lin, et al.
Publicado: (2023)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization
por: Li, SiChan, et al.
Publicado: (2022)

The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: van Gelder, Teun, et al.
Publicado: (2020)

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats
por: Lou, Yutao, et al.
Publicado: (2023)

Combination of Intracameral and Intrastromal Voriconazole in the Treatment of Recalcitrant Acremonium Fungal Keratitis
por: Haddad, Randa S., et al.
Publicado: (2012)

Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazole
por: Sili, Uluhan, et al.
Publicado: (2015)

Intrastromal voriconazole as successful adjunctive approach for recalcitrant deep fungal keratitis
por: Bhirud, Atul, et al.
Publicado: (2023)

Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections
por: de Almeida Campos, Laís, et al.
Publicado: (2023)

Frequency of the CYP2C19*17 polymorphism in a Chilean population and its effect on voriconazole plasma concentration in immunocompromised children
por: Espinoza, N., et al.
Publicado: (2019)

Impact of CYP2C19 Polymorphisms on Serum Concentration of Voriconazole in Iranian Hematological Patients
por: Ebrahimpour, Sholeh, et al.
Publicado: (2017)

Successful Treatment of Fungal Osteomyelitis with Voriconazole in a Patient with Chronic Granulomatous Disease
por: Mohammadpour, Masoud, et al.
Publicado: (2010)

Fungal Keratitis Caused by Drechslera spp. Treated with Voriconazole: A Case Report
por: Echavez, Margarita I., et al.
Publicado: (2013)

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole
por: Mithal, Kopal, et al.
Publicado: (2015)

Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia
por: Lee, Kyu Ho, et al.
Publicado: (2017)

Intrastromal injection of voriconazole as a therapeutic of fungal hypopyon: a case report
por: Albab, Nabil, et al.
Publicado: (2020)

Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases
por: Shen, Kunlu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jgcofge3fuu25gr8mj7qsvbcbd